PRKN and neuroblastoma: It is reported that KEN modulates parkin recruitment to mitochondria,[18] prevents hearing loss,[19] increases neuronal differentiation,[20] and prolongs healthy survival of motor neurons.[21] Intriguingly, this molecule seems to have anticancer activity but is also anti‐apoptotic in neurodegeneration.[22] To explore the potential role of KEN in ADAM10 expression, we first measured ADAM10 protein levels in SH‐SY5Y (neuroblastoma) cells.